References
Brown MS, Goldstein JR (1987) Plasma lipoproteins: teaching old dogmas new tricks. Nature 330: 113–114
Chesebro JH, Knatterud G, Roberts R, Borer J, Cohen LS, Dalen J, Dodge HT, Francis CK, Hillis D, Ludbrook P, Markis JE, Mueller H, Passamani ER, Powers ER, Rao AK, Robertson T, Ross A, Ryan TJ, Sobel BE, Willerson J, Williams DO, Zaret BL, Braunwald E (1987) Thrombolysis in myocardial infarction (TIMI) trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Circulation 76: 142–154
Edelberg JM, Gonzalez-Gronow M, Pizzo SV (1990) Lipoprotein (a) inhibition of plasminogen activation by tissue-type plasminogen activator. Thromb Res 57: 155–162
Hamsten A, Walldius G, Szamosi A, Blomback, M, Faire U, Dahlen G, Landou C, Wiman B (1987) Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet ii: 3–9
Karadi I, Kostner GM, Gries A, Nimpf J, Romics L, Malle E (1988) Lipoprotein (a) and plasminogen are immunochemically related. Biochim Biophys Acta 960: 91–97
Maeda S, Abe A, Seishima M, Makino K, Noma A, Kawade M (1989) Transient changes of serum lipoprotein (a) as an acute phase protein. Atherosclerosis 78: 145–150
McLean JW, Tomlinson JE, Kuang W-J, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM (1987) cDNA sequence of human apolipoprotein (a) is homologous to plasminogen. Nature 330: 132–137
Miles LA, Fless GM, Levin EG, Scanu AM, Plow EF (1989) A potential basis for the thrombotic risks associated with lipoprotein (a). Nature 339: 301–305
Tranchesi B, Verstraete M, Vanhove Ph, Van de Werf F, Chamone DF, Bellotti G, Pileggi F (1990) Intravenous bolus administration of recombinant tissue plasminogen activator to patients with acute myocardial infarction. Cor Art Dis 1: 83–88
Uterman G (1989) The mysteries of Lp(a). Science 246: 904–910
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tranchesi, B., Filho, R.S., Vinagre, C. et al. Lipoprotein (a) levels do not influence the outcome of rt-PA therapy in acute myocardial infarction. Ann Hematol 62, 141–142 (1991). https://doi.org/10.1007/BF01702928
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01702928